Cargando…

Effect of pretreatment prostate volume on urinary quality of life following intensity-modulated radiation therapy for localized prostate cancer

BACKGROUND: The aim of this study was to describe the effect of pretreatment prostate volume on urinary quality of life after intensity-modulated radiation therapy (IMRT) for clinically localized prostate cancer. METHODS: A total of 368 men treated with prostate IMRT (77.4–81 Gy) were stratified int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chevli, Connor, Narayanan, Ramkishen, Rambarran, Lisa, Kubicek, Gregory, Chevli, K Kent, Duff, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827019/ https://www.ncbi.nlm.nih.gov/pubmed/24400232 http://dx.doi.org/10.2147/RRU.S38093

Ejemplares similares

Low incidence of prostate cancer identified in the transition and anterior zones with transperineal biopsy
por: Danforth, Teresa L, et al.
Publicado: (2012)

Sensorimotor polyneuropathy and foot-drop as result of a prostate cancer paraneoplastic syndrome
por: Bodkin, John J, et al.
Publicado: (2013)

Use of Glycoproteins—Prostate-Specific Membrane Antigen and Galectin-3 as Primary Tumor Markers and Therapeutic Targets in the Management of Metastatic Prostate Cancer
por: Sharma, Satish, et al.
Publicado: (2022)

Solitary Leptomeningeal Recurrence From Prostate Adenocarcinoma After Treatment With Cytotoxic Gene Therapy, Radiation Therapy, and Androgen Deprivation Therapy
por: Chevli, Neil, et al.
Publicado: (2021)

Bilateral spermatocytic seminoma: a case report
por: Narins, Hadley, et al.
Publicado: (2014)

P1061: INDIRECT TREATMENT COMPARISONS OF FEDRATINIB VERSUS NAVITOCLAX PLUS RUXOLITINIB: EFFECT ON SPLEEN VOLUME AND SYMPTOMS IN RUXOLITINIB-EXPOSED MYELOFIBROSIS PATIENTS
por: Abraham, P., et al.
Publicado: (2022)

Pretreatment Tumor Volume Estimation Based on Total Serum PSA in Patients with Localized Prostate Cancer
por: Kato, Raphael Barroso, et al.
Publicado: (2008)

Early Experiences of Image Guided Prostate and Pelvic Nodal Irradiation With Intensity Modulated Radiation Treatment in Localized Prostate Cancer
por: Ko, Christine, et al.
Publicado: (2012)

A Clinicopathological Profile of Prostate Cancer in Trinidad and Tobago
por: Hosein, Ian, et al.
Publicado: (2016)

Case-Matched Outcomes of Proton Beam and Intensity-Modulated Radiation Therapy for Localized Prostate Cancer
por: Bao, Alicia, et al.
Publicado: (2023)

cExternal beam radiation results in minimal changes in post void residual urine volumes during the treatment of clinically localized prostate cancer
por: Orio, Peter F, et al.
Publicado: (2009)

P1058: REAL-WORLD OUTCOMES WITH FEDRATINIB THERAPY IN PATIENTS WITH PRIMARY MYELOFIBROSIS POST-RUXOLITINIB DISCONTINUATION
por: Passamonti, F., et al.
Publicado: (2022)

Relationship between prostate volume changes and treatment duration of neoadjuvant androgen deprivation during intensity-modulated radiation therapy for Japanese patients with prostate cancer
por: Tomida, Masashi, et al.
Publicado: (2016)

Reimbursement and use of intensity-modulated radiation therapy for prostate cancer
por: Shahinian, Vahakn B., et al.
Publicado: (2017)

Toxicity and efficacy of three dose-fractionation regimens of intensity-modulated radiation therapy for localized prostate cancer
por: Manabe, Yoshihiko, et al.
Publicado: (2014)

Urinary Morbidity in Men Treated With Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer Following Transurethral Resection of the Prostate (TURP)
por: Pepin, Abigail, et al.
Publicado: (2020)

Comparative Cost-Effectiveness of Stereotactic Body Radiation Therapy Versus Intensity-Modulated and Proton Radiation Therapy for Localized Prostate Cancer
por: Parthan, Anju, et al.
Publicado: (2012)

Impact and Outcomes of Pretreatment Total Serum Testosterone on Localized Prostate Cancer Patients
por: Usera, Brittni M., et al.
Publicado: (2020)

Urinary quality of life outcomes in men who were treated with image-guided intensity-modulated radiation therapy for prostate cancer
por: Salami, Simpa S., et al.
Publicado: (2016)

Older Age and Larger Prostate Volume Are Associated with Stress Urinary Incontinence after Plasmakinetic Enucleation of the Prostate
por: Xu, Ning, et al.
Publicado: (2017)

Spontaneous coronary artery dissection causing acute coronary syndrome in a young patient without risk factors
por: Chevli, Parag, et al.
Publicado: (2014)

Intensity modulated radiotherapy for localized prostate cancer: rigid compliance to dose-volume constraints as a warranty of acceptable toxicity?
por: Chen, Michael J, et al.
Publicado: (2007)

Normalization of prostate specific antigen in patients treated with intensity modulated radiotherapy for clinically localized prostate cancer
por: Schmitz, Matthew D, et al.
Publicado: (2010)

Prostate cancer treated with reduced-volume intensity-modulated radiation therapy: Report on the 5-year outcome of a prospective series
por: Luo, Hua-Chun, et al.
Publicado: (2017)

Correlation of Prostatic Urethral Angle with the Severity of Urinary Symptom and Peak Flow Rate in Men with Small Prostate Volume
por: Kang, Dong Hyuk, et al.
Publicado: (2014)

Interrelationships Between American Heart Association's Life's Simple 7, ECG Silent Myocardial Infarction, and Cardiovascular Mortality
por: Ahmad, Muhammad Imtiaz, et al.
Publicado: (2019)

Longitudinal change in health-related quality of life after intensity-modulated radiation monotherapy for clinically localized prostate cancer
por: Yamamoto, Shinya, et al.
Publicado: (2013)

A pilot study of highly hypofractionated intensity-modulated radiation therapy over 3 weeks for localized prostate cancer
por: Nakamura, Kiyonao, et al.
Publicado: (2018)

Utility of Smart Arc CDR for intensity-modulated radiation therapy for prostate cancer
por: Hatanaka, Shogo, et al.
Publicado: (2014)

Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
por: Chen, Leonard N, et al.
Publicado: (2014)

Effect of Large Prostate Volume on Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy in Patients With Prostate Cancer
por: Natesan, Divya, et al.
Publicado: (2021)

Importance of prostate volume and urinary flow rate in prediction of bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia
por: Trumbeckas, Darius, et al.
Publicado: (2011)

Effects of Obesity on Prostate Volume and Lower Urinary Tract Symptoms in Korean Men
por: Kim, Geun Woo, et al.
Publicado: (2010)

The effect of pharmacotherapy on prostate volume, prostate perfusion and prostate-specific antigen (prostate morphometric parameters) in patients with lower urinary tract symptoms and benign prostatic obstruction. A systematic review and meta-analysis
por: Sakalis, Vasileios, et al.
Publicado: (2021)

Pretreatment prostate specific antigen doubling time as prognostic factor in prostate cancer patients
por: Zharinov, Gennady M., et al.
Publicado: (2017)

External beam radiation therapy or high intensity focused ultrasound for localized prostate cancer: a matched pair analysis in the prostate-specific antigen era
por: Gelet, Albert, et al.
Publicado: (2015)

Correlation between patients’ anatomical characteristics and interfractional internal prostate motion during intensity modulated radiation therapy for prostate cancer
por: Maruoka, Shintaroh, et al.
Publicado: (2015)

Long-term outcomes of prostate intensity-modulated radiation therapy incorporating a simultaneous intra-prostatic MRI-directed boost
por: Laughlin, Brady S., et al.
Publicado: (2022)

Outcomes of high-dose intensity-modulated radiotherapy alone with 1 cm planning target volume posterior margin for localized prostate cancer
por: Gadia, Rafael, et al.
Publicado: (2013)

Intensity-Modulated Radiotherapy with Regional Hyperthermia for High-Risk Localized Prostate Carcinoma
por: Nakahara, Sota, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hdcio6vt9j4bnqbtqpme8rjnmd